Overview and Scope
Plasma therapy refers to a treatment that substitutes missing or inadequate proteins to help people live healthier and more fruitful lives. It introduces antibodies into individuals receiving therapy using blood donated by recovered patients.
Sizing and Forecast
The plasma therapy market size has grown rapidly in recent years. It will grow from $0.49 billion in 2023 to $0.55 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing awareness of the benefits of plasma therapy, government support for plasma therapy, reimbursement coverage for plasma therapy, increasing demand for minimally invasive procedures, rising demand for personalized medicine, growing geriatric population.
The plasma therapy market size is expected to see rapidly grown in the next few years. It will grow to $0.88 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of immunoglobulins, expanding applications, rising demand for rare diseases treatment, customized therapies. Major trends in the forecast period include development of new and improved plasma therapy techniques, biological manufacturing, cell-free plasma therapies, telemedicine integration, research into new applications.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report
Segmentation & Regional Insights
The plasma therapy market covered in this report is segmented –
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes
North America was the largest region in the plasma therapy market in 2023. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp
Major Driver Impacting Market Growth
The rising cases of osteoarthritis are expected to drive the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a type of plasma therapy, is considered a safe and efficient treatment for osteoarthritis. Platelet-rich plasma (PRP) is a concentrated autologous blood growth factor that is injected into the joint to provide symptomatic relief by decreasing inflammation and slowing the progression of osteoarthritis. For instance, in September 2023, according to the Journal of Elsevier, a Netherlands-based publishing company, by 2050, compared to the numbers from 2020, the projected rise in osteoarthritis cases globally is expected to be 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Therefore, an increase in the prevalence of osteoarthritis is expected to drive the plasma therapy market.
Key Industry Players
Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Grifols International S.A., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.
The plasma therapy market report table of contents includes:
1. Executive Summary
2. Plasma Therapy Market Characteristics
3. Plasma Therapy Market Trends And Strategies
4. Plasma Therapy Market – Macro Economic Scenario
5. Global Plasma Therapy Market Size and Growth
.
.
.
31. Global Plasma Therapy Market Competitive Benchmarking
32. Global Plasma Therapy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Plasma Therapy Market
34. Plasma Therapy Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
